NCT01770080View on ClinicalTrials.gov

Efficacy of Euminz® for Tension-Type Headache

PHASE4CompletedINTERVENTIONAL
Enrollment

211

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Episodic Tension-Type Headache
Interventions
DRUG

Euminz®

3 to 5 time topical use of study drug.

DRUG

Placebo

3 to 5 time topical use of study drug.

Trial Locations (1)

14109

Charité, Chair of Complementary and Integrative Medicine, Berlin

All Listed Sponsors
collaborator

Cassella-med GmbH & Co. KG

INDUSTRY

lead

Charite University, Berlin, Germany

OTHER

NCT01770080 - Efficacy of Euminz® for Tension-Type Headache | Biotech Hunter | Biotech Hunter